The “New” Prostate Cancer InfoLink encourages prostate cancer patients and their partners to take the online prostate cancer sexuality survey on the ProstaidCalgary web site.
Filed under: Living with Prostate Cancer | Comments Off
Prostate cancer news reports: Saturday, November 21, 2009
Posted on November 21, 2009 by Sitemaster
In today’s prostate cancer news reports there are brief comments on a number of interesting (if technically dense) articles dealing with such topics as:
- The need for regularity of post-treatment PSA testing
- Surgical outcomes of men with Gleason 8-10 disease over 20 years of experience
- Loss of penile length after radical prostatectomy
- Is stage T4 a necessary component of the AJCC staging system for prostate cancer? … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: frequency, Gleason 8-10, outcomes, post-surgery, PSA, stage T4 | Leave a Comment »
Japanese experience with HIFU over 8 years
Posted on November 21, 2009 by Sitemaster
Investigators at Tokai University Hachioji Hospital in Tokyo have been using high-intensity, focused ultrasound (HIFU) to treat men with localized prostate cancer since January 1999. A newly-published paper provides a complete report on this experience. … READ MORE …
Filed under: Management, Treatment | Tagged: HIFU, high-intensity focused ultrasound, outcome | Leave a Comment »
FDA to rule on approval of Provenge by May 2010
Posted on November 20, 2009 by Sitemaster
According to a Reuters report this morning, the U.S. Food and Drug Administration has advised Dendreon that the company can expect a ruling on the approval of sipuleucel-T (Provenge), the company’s investigational immunotherapeutic agent for the treatment of hormone-refractory prostate cancer, on or before May 1, 2010.
Filed under: Drugs in development | Tagged: Provenge, sipuleucel-T | Leave a Comment »
Prostate cancer recurrence, PSADT, and patient comorbidities
Posted on November 20, 2009 by Sitemaster
D’Amico and his colleagues demonstrated some time ago that PSA velocity and PSA doubling time (PSADT) are valuable tools in predicting which patients with recurrent prostate cancer after first-line treatment are at greatest risk of metastatic disease and prostate cancer-specific mortality. But they have now shown that PSADT is less predictive of risk in men with other “comorbid” health problems. … READ MORE …
Filed under: Management, Treatment | Tagged: comorbidity, PSA doubling time, PSA velocity, PSADT, recurrence | Leave a Comment »
Do dietary patterns really affect risk for prostate cancer?
Posted on November 20, 2009 by Sitemaster
Over the years a variety of factors have suggested an association between diet and risk for prostate cancer — with a particular emphasis on the “dangers” of larger quantities of things like red meat, meat fats, and milk-based products in the diet. … READ MORE …
Filed under: Risk | Tagged: diet, risk | 4 Comments »
How to calculate (and use) your CAPRA score
Posted on November 19, 2009 by Sitemaster
The CAPRA score — which stands for “Cancer of the Prostate Risk Assessment” score — was developed at the University of San Francisco as a method to assess risk of prostate cancer progression based on risk for metastases or prostate cancer-specific mortality. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: CAPRA, risk, score | Leave a Comment »
More on the value of HDR brachytherapy added to EBRT
Posted on November 19, 2009 by Sitemaster
A few days ago we reported on a study which concluded that the addition of high-dose-rate (HDR) brachytherapy to intensity-modulated radiation therapy (IMRT) had limited short-term clinical benefit in the treatment of localized prostate cancer compared to IMRT alone. Newly published Australian data is arguably supportive of this viewpoint. … READ MORE …
Filed under: Management, Treatment | Tagged: 3D-CRT, brachytherapy, conformational radiation therapy, HDR, high-dose-rate, outcomes, three-dimensional | Leave a Comment »
YouTube as a source of prostate cancer information
Posted on November 19, 2009 by Sitemaster
Researchers at Dartmouth-Hitchcock Medical Center in New Hampshire have analyzed the prostate cancer videos on YouTube for information content and the presence of bias. They conclude that, “although some videos are robust sources of information, given the preponderance of modest and unbalanced information among reviewed videos, YouTube is an inadequate source of prostate cancer information for patients.” … READ MORE …
Filed under: Diagnosis, Management, Tips | Tagged: education, video, YouTube | 2 Comments »
Avanafil shows highly positive results in Phase 3 trial for ED
Posted on November 18, 2009 by Sitemaster
According to a company press release issued earlier today by VIVUS, Inc., avanafil, an investigational agent, was effective in the treatment of erectile dysfunction (ED) in some 77 percent of patients at a dose of 200 mg. … READ MORE …
Filed under: Living with Prostate Cancer | Tagged: avanafil, ED, erectile dysfunction | Leave a Comment »
The Sunnybrook active surveillance experience
Posted on November 17, 2009 by Sitemaster
Three articles published in the past few days provide additional insights into the potential of active surveillance as a management strategy for early stage, relatively low risk prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: active surveillance | Leave a Comment »
Evolution of “single port” laparoscopic prostate surgery
Posted on November 17, 2009 by Sitemaster
Early in the existence of The “New” Prostate Cancer InfoLink, in an article entitled “A note on NOTES,” Dr. Krongrad reported from an early medical meeting on the potential for “Natural Orifice Translumenal Endoscopic Surgery,” … READ MORE …
Filed under: Management, Treatment | Tagged: single-port, surgery | Leave a Comment »
Strict leak- and pad-free continence after RALP: is this the real truth?
Posted on November 16, 2009 by Sitemaster
The issue of complete continence after radical prostatectomy is a subject that few in the urologic surgery community have addressed in thorough detail. However, a new article based on data from a single-institution series of patients at the University of Chicago may have finally opened the doors to some honesty about this topic. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: continence, RALP, surgery | 13 Comments »
Prostate cancer news report: Monday, November 16, 2009
Posted on November 16, 2009 by Sitemaster
Three reports discussed today address the refinement of risk information in the diagnosis and prognosis of prostate cancer, with specific regard to:
- Whether PSA levels should be adjusted based on BMI
- The prediction of Gleason score upstaging after surgery
- Tumor volume and percent cancer as predictors of prostate cancer progression post-surgery … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: BMI, Gleason score, obesity, percent cancer, PSA, tunor volume, upstaging | Leave a Comment »
Prostate cancer news reports: Friday, November 13, 2009
Posted on November 13, 2009 by Sitemaster
In today’s prostate cancer news reports we have noted items on:
- The Prostate Cancer Risk Calculator and its use in community practice
- Potential guidelines on prostate cancer management for the elderly
- The relative risk of single focus as compared to multifocal disease … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: elderly, guidelines, multifocal, Prostate Cancer Risk Calculator, single focus | 1 Comment »
SUPPORT 
Search for new and
ongoing trials on the
CTAG PCa web site
